Home Health News Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study

Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study

67 min read
Comments Off on Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study



The COVID-19 pandemic and efforts to scale back SARS-CoV-2 transmission considerably affected health providers worldwide. To higher perceive the impression of the pandemic on childhood routine immunisation, we estimated disruptions in vaccine coverage related to the pandemic in 2020, globally and by Global Burden of Disease (GBD) super-region.


For this evaluation we used a two-step hierarchical random spline modelling strategy to estimate global and regional disruptions to routine immunisation utilizing administrative knowledge and stories from digital immunisation methods, with mobility knowledge as a mannequin enter. Paired with estimates of vaccine coverage anticipated in the absence of COVID-19, which have been derived from vaccine coverage fashions from GBD 2020, Release 1 (GBD 2020 R1), we estimated the variety of youngsters who missed routinely delivered doses of the third-dose diphtheria-tetanus-pertussis (DTP3) vaccine and first-dose measles-containing vaccine (MCV1) in 2020.


Globally, in 2020, estimated vaccine coverage was 76·7% (95% uncertainty interval 74·3–78·6) for DTP3 and 78·9% (74·8–81·9) for MCV1, representing relative reductions of 7·7% (6·0–10·1) for DTP3 and 7·9% (5·2–11·7) for MCV1, in contrast to anticipated doses delivered in the absence of the COVID-19 pandemic. From January to December, 2020, we estimated that 30·0 million (27·6–33·1) youngsters missed doses of DTP3 and 27·2 million (23·4–32·5) youngsters missed MCV1 doses. Compared to anticipated gaps in coverage for eligible youngsters in 2020, these estimates represented an extra 8·5 million (6·5–11·6) youngsters not routinely vaccinated with DTP3 and an extra 8·9 million (5·7–13·7) youngsters not routinely vaccinated with MCV1 attributable to the COVID-19 pandemic. Globally, month-to-month disruptions have been highest in April, 2020, throughout all GBD super-regions, with 4·6 million (4·0–5·4) youngsters lacking doses of DTP3 and 4·4 million (3·7–5·2) youngsters lacking doses of MCV1. Every GBD super-region noticed reductions in vaccine coverage in March and April, with the most extreme annual impacts in north Africa and the Middle East, south Asia, and Latin America and the Caribbean. We estimated the lowest annual reductions in vaccine supply in sub-Saharan Africa, the place disruptions remained minimal all through the 12 months. For some super-regions, together with southeast Asia, east Asia, and Oceania for each DTP3 and MCV1, the high-income super-region for DTP3, and south Asia for MCV1, estimates recommend that month-to-month doses have been delivered at or above anticipated ranges during the second half of 2020.


Routine immunisation providers confronted stark challenges in 2020, with the COVID-19 pandemic inflicting the most widespread and largest global disruption in current historical past. Although the newest coverage trajectories level in direction of restoration in some areas, a mixture of lagging catch-up immunisation providers, continued SARS-CoV-2 transmission, and persistent gaps in vaccine coverage earlier than the pandemic nonetheless left hundreds of thousands of youngsters under-vaccinated or unvaccinated in opposition to preventable ailments at the finish of 2020, and these gaps are doubtless to lengthen all through 2021. Strengthening routine immunisation knowledge methods and efforts to goal sources and outreach might be essential to minimise the danger of vaccine-preventable illness outbreaks, attain youngsters who missed routine vaccine doses during the pandemic, and speed up progress in direction of greater and extra equitable vaccination coverage over the subsequent decade.


Bill & Melinda Gates Foundation.


SARS-CoV-2, the virus accountable for COVID-19, quickly developed from a localised outbreak in December, 2019, into a pandemic accountable for greater than 79 million confirmed circumstances and 1·7 million deaths worldwide by the finish of 2020.

Weekly epidemiological replace.